Braden Michael Leonard Satsuma Pharmaceuticals, Inc. (STSA) insider trading activity

Braden Michael Leonard is > 10% Shareholder of Satsuma Pharmaceuticals, Inc.. Currently has a direct ownership of 150,000 shares of STSA, which is worth approximately $0. The most recent transaction as insider was on Nov 21, 2022, when has been sold 150,000 shares (Common Stock) at a price of $0.71 per share, resulting in proceeds of $106,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 150K

0% 3M change

0% 12M change

Total Value Held $0

Braden Michael Leonard Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Nov 21 2022	BUY Open market or private purchase	$106,500 $0.71 p/Share	150,000 Added 50.0%	150,000 Common Stock

Also insider at

GMTX

Gemini Therapeutics, Inc. Healthcare

> 10% Shareholder

IMRA

IMARA Inc. Healthcare

> 10% Shareholder

RVP

RETRACTABLE TECHNOLOGIES INC Healthcare

> 10% Shareholder

ASTC

ASTROTECH Corp Industrials

> 10% Shareholder

MTCR

Metacrine, Inc. Healthcare

> 10% Shareholder

CYT

Cyteir Therapeutics, Inc. Healthcare

AVRO

AVROBIO, Inc. Healthcare

RPHM

Reneo Pharmaceuticals, Inc. Healthcare

ACRS

Aclaris Therapeutics, Inc. Healthcare

BML